School of Medicine


Showing 881-900 of 955 Results

  • Mirko Uljarevic

    Mirko Uljarevic

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    BioI am a medically trained researcher focused academic with a background in developmental psychopathology, psychometrics and big data science. My research takes a life-span perspective and is driven by the urgent need to improve outcomes for people with autism and other neuropsychiatric (NPD) disorders and neurodevelopmental conditions (NDD). My primary research interest has focused on combining cutting-edge psychometric procedures and a big data approach to better understand structure of clinical phenotypes across autism and other NPD and NDD and on using this knowledge to improve existing and develop new clinical assessments that are more effective for screening and diagnosis, tracking the natural and treatment-related symptom progression and for use in genetic and neurobiological studies. In addition to my focus on the development of outcome measures, I have collaborated with leading psychopathology researchers and groups in the United States, Europe and Australia on numerous projects spanning a range of topics including genetics, treatment and employment, with a particular focus on understanding risk and resilience factors underpinning poor mental health outcomes in adolescents and adults. Most recently, through several competitively funded projects, I have led the statistical analyses to uncover the latent structure of social and communication and restricted and repetitive behaviors (RRB) clinical phenotypes across NPD and NDD. These findings have enabled us to (i) start capturing and characterizing a highly variable social functioning phenotype across a range of disorders and understanding mechanisms underpinning this variability, (ii) combine phenotypic and genetic units of analyses to advance our understanding of the genetic architecture of RRB, and (iii) focus on identification and characterization of subgroups of individuals that share distinct symptom profiles and demonstrate clinical utility and neurobiological validity. Importantly, this work has provided key information for developing a programmatic line of research aimed at developing novel, comprehensive assessment protocols that combine parent and clinician reports, objective functioning indicators and incorporate state-of-the-art psychometric, mobile and connected technologies and procedures.

    I am a co-director of the recently established Program for Psychometrics and Measurement-Based Care (https://med.stanford.edu/sppmc.html) that aims to bring together world-leading expertise in clinical science, psychometrics, and big data analytics to bridge the gap between the science of measurement development and clinical practice and bring improvements to both clinical care and research.

  • Alexander Eckehart Urban

    Alexander Eckehart Urban

    Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator) and of Genetics

    Current Research and Scholarly InterestsComplex behavioral and neuropsychiatric phenotypes often have a strong genetic component. This genetic component is often extremely complex and difficult to dissect. The current revolution in genome technology means that we can avail ourselves to tools that make it possible for the first time to begin understanding the complex genetic and epigenetic interactions at the basis of the human mind.

  • PJ Utz

    PJ Utz

    Professor of Medicine (Immunology and Rheumatology)

    Current Research and Scholarly InterestsThe long-term research goal of the Utz laboratory is to understand autoimmunity, autoantibodies, and how tolerance is broken and can be reestablished.

  • Tulio Valdez, MD, MSc

    Tulio Valdez, MD, MSc

    Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Pediatrics

    BioDr. Tulio A Valdez is a surgeon scientist born and raised in Colombia with a subspecialty interest in Pediatric Otolaryngology. He attended medical school at Universidad Javeriana in Bogota Colombia before undertaking his residency in Otolaryngology, Head and Neck Surgery in Boston. He completed his Pediatric Otolaryngology Fellowship at Texas Children’s Hospital (2007), Houston and obtained his Master’s in Clinical and Translational Research at the University of Connecticut.

    Clinically, Dr. Valdez has an interest in pediatric sleep apnea. He has a special interest in the management of sinus disease in cystic fibrosis. Dr. Valdez has co-authored one textbook and numerous book chapters and scientific manuscripts. Dr. Valdez continues his clinical research in these areas, particularly with a focus on aerodigestive disorders.

    Scientifically, Dr. Valdez has developed various imaging methods to diagnose otitis media and cholesteatoma a middle ear condition that can lead to hearing loss. He was part of the Laser Biomedical Research Center at the Massachusetts Institute of Technology. His research includes novel imaging modalities to better diagnose ear infections one of the most common pediatric problems. His research has now expanded to include better intraoperative imaging modalities in pediatric patients to improve surgical outcomes without the need for radiation exposure. 

    Dr. Valdez believes in multi-disciplinary collaborations to tackle medical problems and has co-invented various medical devices and surgical simulation models.

  • Matt van de Rijn

    Matt van de Rijn

    Sabine Kohler, MD, Professor of Pathology, Emeritus

    Current Research and Scholarly InterestsOur research focuses on molecular analysis of human soft tissue tumors (sarcomas) with an emphasis on leiomyosarcoma and desmoid tumors. In addition we study the role of macrophages in range of malignant tumors.

  • Keith Van Haren, MD

    Keith Van Haren, MD

    Associate Professor of Neurology and Neurological Sciences (Pediatric Neurology) and of Pediatrics

    Current Research and Scholarly InterestsOur research team is working to develop new treatments for children at risk of neurodegenerative diseases. We are primarily focused on multiple sclerosis and X-linked adrenoleukodystrophy, two conditions that involve inflammatory and metabolic disruption of the myelin that insulates brain cells. A key area of interest for us is how nutrient deficiencies during childhood may contribute to the disease processes and whether nutritional interventions could play a role in prevention.

  • Krisa Van Meurs

    Krisa Van Meurs

    Rosemarie Hess Professor, Emerita

    Current Research and Scholarly InterestsMy research interests include persistent pulmonary hypertension of the newborn, hypoxic respiratory failure, inhaled nitric oxide therapy, ECMO, congenital diaphragmatic hernia, neonatal clinical trials, and the use of aEEG and NIRS to detect brain injury.

  • Capucine Van Rechem

    Capucine Van Rechem

    Assistant Professor of Pathology (Pathology Research)

    Current Research and Scholarly InterestsMy long-term interest lies in understanding the impact chromatin modifiers have on disease development and progression so that more optimal therapeutic opportunities can be achieved. My laboratory explores the direct molecular impact of chromatin-modifying enzymes during cell cycle progression, and characterizes the unappreciated and unconventional roles that these chromatin factors have on cytoplasmic function such as protein synthesis.

  • Shreyas Vasanawala, MD/PhD

    Shreyas Vasanawala, MD/PhD

    William R. Brody Professor of Pediatric Radiology and Child Health

    Current Research and Scholarly InterestsOur group is focused on developing new fast and quantitative MRI techniques.

  • Alexander Michael Vezeridis, MD, PhD

    Alexander Michael Vezeridis, MD, PhD

    Assistant Professor of Radiology (Interventional Radiology)

    BioAlexander Vezeridis MD, PhD is an Assistant Professor of Radiology at Stanford University School of Medicine, and a physician-scientist specializing in Interventional Radiology. His clinical expertise includes interventional oncology, biliary disease and endoscopy, venous disease, portal hypertension, urologic interventions, women’s and men’s health interventions, and general vascular/interventional radiology.

    Dr. Vezeridis is an active researcher with expertise in translational techniques in engineering to make image-guided interventions safer and more effective for patients.

    Dr. Vezeridis obtained his undergraduate, MD, and PhD degrees from Boston University. He completed a two year post-doctoral training at UC San Diego in ultrasound molecular imaging under the auspices of the Cancer Researchers in Nanotechnology (CRIN) R25T, followed by residency and fellowship at UC San Diego.

    Dr. Vezeridis is highly committed to training the next generation, including students, residents, fellows, and engineering graduate students through co-directing Bio301B.

    Dr. Vezeridis has a strong interest in medical device development and commercialization, and completed the Stanford Biodesign Faculty Fellowship.

  • Anne Villeneuve

    Anne Villeneuve

    Berthold and Belle N. Guggenhime Professor and Professor of Developmental Biology and of Genetics

    Current Research and Scholarly InterestsMechanisms underlying homologous chromosome pairing, DNA recombination and chromosome remodeling during meiosis, using the nematode Caenorhabditis elegans as an experimental system. High-resolution 3-D imaging of dynamic reorganization of chromosome architecture. Role of protease inhibitors in regulating sperm activation.

  • David Vu

    David Vu

    Clinical Associate Professor, Pediatrics - Infectious Diseases

    BioDr. Vu is a pediatric infectious diseases specialist who is researching human responses to dengue virus and malaria infections. He performed his undergraduate studies at the University of California, San Diego, and obtained his medical doctorate at the University of Pennsylvania School of Medicine. He trained in general pediatrics at UCSF Benioff Children's Hospital Oakland, and in pediatric infectious diseases at Emory University School of Medicine. His present studies on pediatric dengue and malaria co-infection are supported by an NIAID Career Development Award (K23 AI127909) and a Instructor K Award Support Program Award from the Maternal & Child Health Research Institute and Department of Pediatrics.

  • Soichi Wakatsuki

    Soichi Wakatsuki

    Professor of Photon Science and of Structural Biology

    Current Research and Scholarly InterestsUbiquitin signaling: structure, function, and therapeutics
    Ubiquitin is a small protein modifier that is ubiquitously produced in the cells and takes part in the regulation of a wide range of cellular activities such as gene transcription and protein turnover. The key to the diversity of the ubiquitin roles in cells is that it is capable of interacting with other cellular proteins either as a single molecule or as different types of chains. Ubiquitin chains are produced through polymerization of ubiquitin molecules via any of their seven internal lysine residues or the N-terminal methionine residue. Covalent interaction of ubiquitin with other proteins is known as ubiquitination which is carried out through an enzymatic cascade composed of the ubiquitin-activating (E1), ubiquitin-conjugating (E2), and ubiquitin ligase (E3) enzymes. The ubiquitin signals are decoded by the ubiquitin-binding domains (UBDs). These domains often specifically recognize and non-covalently bind to the different ubiquitin species, resulting in distinct signaling outcomes.
    We apply a combination of the structural (including protein crystallography, small angle x-ray scattering, cryo-electron microscopy (Cryo-EM) etc.), biocomputational and biochemical techniques to study the ubiquitylation and deubiquitination processes, and recognition of the ubiquitin chains by the proteins harboring ubiquitin-binding domains. Current research interests including SARS-COV2 proteases and their interactions with polyubiquitin chains and ubiquitin pathways in host cell responses, with an ultimate goal of providing strategies for effective therapeutics with reduced levels of side effects.

    Protein self-assembly processes and applications.
    The Surface layers (S-layers) are crystalline protein coats surrounding microbial cells. S-layer proteins (SLPs) regulate their extracellular, self-assembly by crystallizing when exposed to an environmental trigger. We have demonstrated that the Caulobacter crescentus SLP readily crystallizes into sheets both in vivo and in vitro via a calcium-triggered multistep assembly pathway. Observing crystallization using a time course of Cryo-EM imaging has revealed a crystalline intermediate wherein N-terminal nucleation domains exhibit motional dynamics with respect to rigid lattice-forming crystallization domains. Rate enhancement of protein crystallization by a discrete nucleation domain may enable engineering of kinetically controllable self-assembling 2D macromolecular nanomaterials. In particular, this is inspiring designing robust novel platform for nano-scale protein scaffolds for structure-based drug design and nano-bioreactor design for the carbon-cycling enzyme pathway enzymes. Current research focuses on development of nano-scaffolds for high throughput in vitro assays and structure determination of small and flexible proteins and their interaction partners using Cryo-EM, and applying them to cancer and anti-viral therapeutics.

    Multiscale imaging and technology developments.
    Multimodal, multiscale imaging modalities will be developed and integrated to understand how molecular level events of key enzymes and protein network are connected to cellular and multi-cellular functions through intra-cellular organization and interactions of the key machineries in the cell. Larger scale organization of these proteins will be studied by solution X-ray scattering and Cryo-EM. Their spatio-temporal arrangements in the cell organelles, membranes, and cytosol will be further studied by X-ray fluorescence imaging and correlated with cryoEM and super-resolution optical microscopy. We apply these multiscale integrative imaging approaches to biomedical, and environmental and bioenergy research questions with Stanford, DOE national labs, and other domestic and international collaborators.

  • Rebecca D. Walker

    Rebecca D. Walker

    Clinical Associate Professor, Emergency Medicine

    Current Research and Scholarly InterestsInterests include international development in emergency care, healthcare disparities, wilderness medicine, human rights, administration

  • Dennis Wall

    Dennis Wall

    Professor of Pediatrics (Clinical Informatics), of Biomedical Data Science and, by courtesy, of Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsSystems biology for design of clinical solutions that detect and treat disease

  • Brian A. Wandell

    Brian A. Wandell

    Isaac and Madeline Stein Family Professor and Professor, by courtesy, of Electrical Engineering, of Ophthalmology and of Education

    Current Research and Scholarly InterestsModels and measures of the human visual system. The brain pathways essential for reading development. Diffusion tensor imaging, functional magnetic resonance imaging and computational modeling of visual perception and brain processes. Image systems simulations of optics and sensors and image processing. Data and computation management for reproducible research.

  • C. Jason Wang, MD, PhD

    C. Jason Wang, MD, PhD

    LCY: Tan Lan Lee Professor and Professor of Pediatrics (General Pediatrics) and of Health Policy

    BioDr. Wang is the Director of Center for Policy, Outcomes and Prevention. Prior to coming to Stanford in 2011, he was a faculty member at Boston University Schools of Medicine and Public Health. His other professional experiences include working as a management consultant with McKinsey and Company and serving as the project manager for Taiwan's National Health Insurance Reform Task-force. His current interests include: 1) pandemic preparedness; 2) role of generative Ai on child health and development; 3) use of mobile technology in improving quality of care; 4) assessing and improving the value of healthcare, and 5) healthcare delivery innovations and payment reforms.